On September 15, Xinchen Capital announced that it has signed a formal agreement with AI-native biotech company Yudao Biotech for its C1 round of financing. Yudao Biotech's current round of financing is tens of millions of dollars. It is co-led by Xinchen Capital and Decheng Capital, with Dachen Caizhi and Zhongsheng Xichuang Dingqi Fund participating; Dianshi Capital acted as the long-term exclusive financial advisor.

Zhitongcaijing · 2d ago
On September 15, Xinchen Capital announced that it has signed a formal agreement with AI-native biotech company Yudao Biotech for its C1 round of financing. Yudao Biotech's current round of financing is tens of millions of dollars. It is co-led by Xinchen Capital and Decheng Capital, with Dachen Caizhi and Zhongsheng Xichuang Dingqi Fund participating; Dianshi Capital acted as the long-term exclusive financial advisor.